A detailed history of Cresset Asset Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Cresset Asset Management, LLC holds 2,279 shares of ARGX stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,279
Previous 1,483 53.67%
Holding current value
$1.43 Million
Previous $637,000 93.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $345,639 - $439,312
796 Added 53.67%
2,279 $1.24 Million
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $62,657 - $79,472
176 Added 13.47%
1,483 $637,000
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $39,264 - $45,461
-110 Reduced 7.76%
1,307 $514,000
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $228,764 - $341,556
675 Added 90.97%
1,417 $539,000
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $274,057 - $406,935
742 New
742 $364,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.